High-normal blood pressure and long-term risk of type 2 diabetes: 35-year prospective population based cohort study of men

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Stahl, Christina H ^a   Novak, Masuma ^a   Lappas, Georgios ^a   Wilhelmsen, Lars ^a   Björck, Lena ^a   Hansson, Per Olof ^a   Rosengren, Annika ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cohort study; Epidemiology; High normal blood pressure; Incidence; Prehypertension; Sweden; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; SYSTOLE;

EID: 84867391526     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-89     Document Type: Article

References (34)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414(6865):782-787. 10.1038/414782a, 11742409.
2. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378(9785):31-40. 10.1016/S0140-6736(11)60679-X, 21705069.
3. Tobias M. Global control of diabetes: information for action. Lancet 2011, 378(9785):3-4. 10.1016/S0140-6736(11)60604-1, 21705073.
4. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011, 378(9786):169-181. 10.1016/S0140-6736(11)60614-4, 21705072.
5. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375(9733):2215-2222. 10.1016/S0140-6736(10)60484-9, 2904878, 20609967.
6. Grundy SM. Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient?. Am J Med 2007, 120(9 Suppl 1):S3-S8. discussion S9.
7. Golden SH, Wang NY, Klag MJ, Meoni LA, Brancati FL. Blood pressure in young adulthood and the risk of type 2 diabetes in middle age. Diabetes Care 2003, 26(4):1110-1115. 10.2337/diacare.26.4.1110, 12663582.
8. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000, 342(13):905-912. 10.1056/NEJM200003303421301, 10738048.
9. Wei GS, Coady SA, Goff DC, Brancati FL, Levy D, Selvin E, Vasan RS, Fox CS. Blood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart study. Diabetes Care 2011, 34(4):873-879. 10.2337/dc10-1786, 3064044, 21346180.
10. Mullican DR, Lorenzo C, Haffner SM. Is prehypertension a risk factor for the development of type 2 diabetes?. Diabetes Care 2009, 32(10):1870-1872. 10.2337/dc09-0328, 2752916, 19628813.
11. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J 2007, 28(23):2937-2943. 10.1093/eurheartj/ehm400, 17925342.
12. Meisinger C, Doring A, Heier M. Blood pressure and risk of type 2 diabetes mellitus in men and women from the general population: the Monitoring Trends and Determinants on Cardiovascular Diseases/Cooperative Health Research in the Region of Augsburg Cohort Study. J Hypertens 2008, 26(9):1809-1815. 10.1097/HJH.0b013e328307c3e9, 18698216.
13. Kramer CK, von Muhlen D, Barrett-Connor E. Mid-life blood pressure levels and the 8-year incidence of type 2 diabetes mellitus: the Rancho Bernardo Study. J Hum Hypertens 2010, 24(8):519-524. 10.1038/jhh.2009.103, 2888977, 20016524.
14. Wilhelmsen L, Lappas G, Rosengren A. Risk of coronary events by baseline factors during 28 years follow-up and three periods in a random population sample of men. J Intern Med 2004, 256(4):298-307. 10.1111/j.1365-2796.2004.01372.x, 15367172.
15. Harmsen P, Lappas G, Rosengren A, Wilhelmsen L. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden. Stroke 2006, 37(7):1663-1667. 10.1161/01.STR.0000226604.10877.fc, 16728686.
16. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, Vedin A, Wilhelmsson C, Werko L. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986, 7(4):279-288.
17. Schaufelberger M, Rosengren A. Heart failure in different occupational classes in Sweden. Eur Heart J 2007, 28(2):212-218.
18. Wilhelmsen L, Berglund G, Werko L. Prevalence and management of hypertension in a general population sample of Swedish men. Prev Med 1973, 2(1):57-66. 10.1016/0091-7435(73)90008-X, 4154438.
19. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999, 17(2):151-183. .
20. McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 1990, 131(3):443-453.
21. Kaplan NM. Hypertension curriculum review: lifestyle modifications for prevention and treatment of hypertension. J Clin Hypertens (Greenwich) 2004, 6(12):716-719.
22. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007, 369(9557):201-207. 10.1016/S0140-6736(07)60108-1, 17240286.
23. Izzo R, de Simone G, Chinali M, Iaccarino G, Trimarco V, Rozza F, Giudice R, Trimarco B, De Luca N. Insufficient control of blood pressure and incident diabetes. Diabetes Care 2009, 32(5):845-850. 10.2337/dc08-1881, 2671117, 19223610.
24. Viera AJ. Predisease: when does it make sense?. Epidemiol Rev 2011, 33(1):122-134. 10.1093/epirev/mxr002, 21624963.
25. Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: a disease of the microcirculation?. Hypertension 2006, 48(6):1012-1017. 10.1161/01.HYP.0000249510.20326.72, 17060505.
26. Nguyen TT, Wang JJ, Islam FM, Mitchell P, Tapp RJ, Zimmet PZ, Simpson R, Shaw J, Wong TY. Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes 2008, 57(3):536-539. 10.2337/db07-1376, 18086902.
27. Serne EH, Stehouwer CD, ter Maaten JC, ter Wee PM, Rauwerda JA, Donker AJ, Gans RO. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 1999, 99(7):896-902. 10.1161/01.CIR.99.7.896, 10027812.
28. Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safar ME, Struijker-Boudier HA. Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation 2008, 118(9):968-976. 10.1161/CIRCULATIONAHA.107.763730, 18725503.
29. Houben AJ, Eringa EC, Jonk AM, Serne EH, Smulders YM, Stehouwer CD. Perivascular Fat and the Microcirculation: Relevance to Insulin Resistance, Diabetes, and Cardiovascular Disease. Curr Cardiovasc Risk Rep 2012, 6(1):80-90. 10.1007/s12170-011-0214-0, 3251783, 22247785.
30. Thuillez C, Richard V. Targeting endothelial dysfunction in hypertensive subjects. J Hum Hypertens 2005, 19(Suppl 1):S21-S25.
31. Meigs JB, O'Donnell CJ, Tofler GH, Benjamin EJ, Fox CS, Lipinska I, Nathan DM, Sullivan LM, D'Agostino RB, Wilson PW. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 2006, 55(2):530-537. 10.2337/diabetes.55.02.06.db05-1041, 16443791.
32. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003, 290(22):2945-2951. 10.1001/jama.290.22.2945, 14665655.
33. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004, 53(3):693-700. 10.2337/diabetes.53.3.693, 14988254.
34. Salas-Salvado J, Bullo M, Babio N, Martinez-Gonzalez MA, Ibarrola-Jurado N, Basora J, Estruch R, Covas MI, Corella D, Aros F, et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011, 34(1):14-19. 10.2337/dc10-1288, 3005482, 20929998.